13-113138440-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000504.4(F10):c.232-17T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.833 in 1,178,712 control chromosomes in the GnomAD database, including 410,365 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.80 ( 48841 hom., cov: 33)
Exomes 𝑓: 0.84 ( 361524 hom. )
Consequence
F10
NM_000504.4 intron
NM_000504.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.31
Publications
8 publications found
Genes affected
F10 (HGNC:3528): (coagulation factor X) This gene encodes the vitamin K-dependent coagulation factor X of the blood coagulation cascade. This factor undergoes multiple processing steps before its preproprotein is converted to a mature two-chain form by the excision of the tripeptide RKR. Two chains of the factor are held together by 1 or more disulfide bonds; the light chain contains 2 EGF-like domains, while the heavy chain contains the catalytic domain which is structurally homologous to those of the other hemostatic serine proteases. The mature factor is activated by the cleavage of the activation peptide by factor IXa (in the intrisic pathway), or by factor VIIa (in the extrinsic pathway). The activated factor then converts prothrombin to thrombin in the presence of factor Va, Ca+2, and phospholipid during blood clotting. Mutations of this gene result in factor X deficiency, a hemorrhagic condition of variable severity. Alternative splicing results in multiple transcript variants encoding different isoforms that may undergo similar proteolytic processing to generate mature polypeptides. [provided by RefSeq, Aug 2015]
F10 Gene-Disease associations (from GenCC):
- congenital factor X deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 13-113138440-T-C is Benign according to our data. Variant chr13-113138440-T-C is described in CliVar as Benign. Clinvar id is 256307.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-113138440-T-C is described in CliVar as Benign. Clinvar id is 256307.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-113138440-T-C is described in CliVar as Benign. Clinvar id is 256307.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-113138440-T-C is described in CliVar as Benign. Clinvar id is 256307.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-113138440-T-C is described in CliVar as Benign. Clinvar id is 256307.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-113138440-T-C is described in CliVar as Benign. Clinvar id is 256307.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-113138440-T-C is described in CliVar as Benign. Clinvar id is 256307.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-113138440-T-C is described in CliVar as Benign. Clinvar id is 256307.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-113138440-T-C is described in CliVar as Benign. Clinvar id is 256307.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.873 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
F10 | NM_000504.4 | c.232-17T>C | intron_variant | Intron 2 of 7 | ENST00000375559.8 | NP_000495.1 | ||
F10 | NM_001312674.2 | c.232-17T>C | intron_variant | Intron 2 of 6 | NP_001299603.1 | |||
F10 | NM_001312675.2 | c.232-17T>C | intron_variant | Intron 2 of 7 | NP_001299604.1 | |||
LOC124903215 | XR_007063879.1 | n.298-559A>G | intron_variant | Intron 1 of 1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.797 AC: 121197AN: 152024Hom.: 48802 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
121197
AN:
152024
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.842 AC: 202335AN: 240164 AF XY: 0.844 show subpopulations
GnomAD2 exomes
AF:
AC:
202335
AN:
240164
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.838 AC: 860113AN: 1026570Hom.: 361524 Cov.: 14 AF XY: 0.839 AC XY: 443520AN XY: 528396 show subpopulations
GnomAD4 exome
AF:
AC:
860113
AN:
1026570
Hom.:
Cov.:
14
AF XY:
AC XY:
443520
AN XY:
528396
show subpopulations
African (AFR)
AF:
AC:
16036
AN:
24964
American (AMR)
AF:
AC:
37093
AN:
40844
Ashkenazi Jewish (ASJ)
AF:
AC:
18986
AN:
22690
East Asian (EAS)
AF:
AC:
33970
AN:
37258
South Asian (SAS)
AF:
AC:
61623
AN:
72728
European-Finnish (FIN)
AF:
AC:
43778
AN:
51980
Middle Eastern (MID)
AF:
AC:
3328
AN:
4172
European-Non Finnish (NFE)
AF:
AC:
607773
AN:
726664
Other (OTH)
AF:
AC:
37526
AN:
45270
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
5951
11902
17852
23803
29754
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
11296
22592
33888
45184
56480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.797 AC: 121287AN: 152142Hom.: 48841 Cov.: 33 AF XY: 0.799 AC XY: 59426AN XY: 74388 show subpopulations
GnomAD4 genome
AF:
AC:
121287
AN:
152142
Hom.:
Cov.:
33
AF XY:
AC XY:
59426
AN XY:
74388
show subpopulations
African (AFR)
AF:
AC:
27538
AN:
41458
American (AMR)
AF:
AC:
13224
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
AC:
2928
AN:
3468
East Asian (EAS)
AF:
AC:
4632
AN:
5178
South Asian (SAS)
AF:
AC:
4034
AN:
4830
European-Finnish (FIN)
AF:
AC:
8958
AN:
10576
Middle Eastern (MID)
AF:
AC:
246
AN:
294
European-Non Finnish (NFE)
AF:
AC:
57344
AN:
68010
Other (OTH)
AF:
AC:
1688
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1206
2412
3619
4825
6031
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
880
1760
2640
3520
4400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2853
AN:
3470
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Nov 11, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Hereditary factor X deficiency disease Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.